FutureTech II Acquisition Corp. Extends SPAC Business Combination Deadline

What Happened
FutureTech II Acquisition Corp. announced that its stockholders approved an amendment to the company’s charter to extend the date by which the SPAC must consummate an initial business combination. At a Special Meeting on August 13, 2026 (record date July 7, 2026), shareholders voted to approve the amendment; the Certificate of Amendment (the “Fifth Amendment”) was filed with the Delaware Secretary of State on August 14, 2026. The new “Extended Termination Date” is May 18, 2027 (previous termination date was August 18, 2026).

Key Details

• Extension approved: from August 18, 2026 → May 18, 2027 (nine-month extension).
• Vote totals: 3,904,200 shares FOR, 0 against, 0 abstentions; these votes represented 96.1% of the 4,061,674 outstanding shares as of the July 7, 2026 record date. Approval required at least 65% of outstanding shares.
• Administrative action: Certificate of Amendment filed with Delaware on August 14, 2026.
• Next steps: The Company and prospective target “Longevity” have prepared and filed a Registration Statement with the SEC; any proposed business combination will be submitted to shareholders for approval and accompanied by a proxy/prospectus.

Why It Matters
This charter amendment gives FutureTech more time to complete a merger or acquisition (the SPAC “business combination”), reducing the immediate risk that the SPAC would reach its prior termination date without a transaction. Investors should note that an extended deadline does not guarantee a deal—any business combination still requires disclosure, SEC review, and shareholder approval, and may be subject to redemptions. Watch for the definitive proxy/prospectus and any updates about the proposed combination with Longevity for key terms and timelines.